Modèles de données sélectionnés

Vous devez être connecté pour sélectionner plusieurs modèles de données, les télécharger ou les analyser.

23 Résultats de recherche.
Pertinence Commentaire Plus récent Moins récent

Eligibility Leukemia NCT02193100

- 25/06/2020 - 1 Formulaire, 2 Groupes Item, 15 Eléments de données, 1 Langue
Groupes Item: Criteria, Exclusion Criteria
Pre and Post Treatment Metabolomic Analysis of Leukemia: A Translational Clinical Trial of the Brown Cancer Center; ODM derived from: https://clinicaltrials.gov/show/NCT02193100

Eligibility Leukemia NCT00897182

- 19/05/2018 - 1 Formulaire, 1 Groupe Item, 11 Eléments de données, 1 Langue
Groupe Item: Criteria
Identifying Cancer Genes in in Blood and Bone Marrow Samples From Patients With Acute Myeloid Leukemia; ODM derived from: https://clinicaltrials.gov/show/NCT00897182

Eligibility NCT00915252 Acute Myeloid Leukemia - Eligibility

- 20/09/2021 - 1 Formulaire, 2 Groupes Item, 24 Eléments de données, 2 Langues
Groupes Item: Inclusion Criteria, Exclusion Criteria
ODM derived from http://clinicaltrials.gov/show/NCT00915252

Eligibility NCT00560794 Acute Lymphoblastic Leukemia - Eligibility

- 20/09/2021 - 1 Formulaire, 2 Groupes Item, 24 Eléments de données, 2 Langues
Groupes Item: Inclusion Criteria, Exclusion Criteria
ODM derived from http://clinicaltrials.gov/show/NCT00560794

ADVL0212: On Study Worksheet (Leukemia) NCT00053963

- 05/07/2015 - 1 Formulaire, 6 Groupes Item, 45 Eléments de données, 1 Langue
Groupes Item: Patient demographics, Bone Marrow, Hemogram, Chemistries, Comments, CCRR MODULE
ADVL0212: On Study Worksheet (Leukemia) NCT00053963 FR901228 in Treating Children With Refractory or Recurrent Solid Tumors or Leukemia Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=C10238B2-42BD-142E-E034-0003BA12F5E7

ADVL0212: Eligibility Worksheet (Leukemia) NCT00053963

- 16/06/2015 - 1 Formulaire, 5 Groupes Item, 33 Eléments de données, 1 Langue
Groupes Item: Header, Eligibility Assessment, Comments, Treatment Assignment, CCRR MODULE
ADVL0212: Eligibility Worksheet (Leukemia) NCT00053963 FR901228 in Treating Children With Refractory or Recurrent Solid Tumors or Leukemia Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=C0F2D219-E599-53B9-E034-0003BA12F5E7

Eligibility DRKS00000733 NCT00867672 Acute Myeloid Leukemia - Eligibility

- 20/09/2021 - 1 Formulaire, 2 Groupes Item, 19 Eléments de données, 2 Langues
Groupes Item: Inclusion Criteria, Exclusion Criteria
ODM derived from http://clinicaltrials.gov/show/NCT00867672

Eligibility Cancer NCT01162551

- 21/12/2015 - 1 Formulaire, 2 Groupes Item, 19 Eléments de données, 1 Langue
Groupes Item: Inclusion Criteria, Exclusion Criteria
Trial of Sirolimus and Methotrexate in Relapsed/Refractory Lymphoblastic Leukemia and Lymphoma; ODM derived from: https://clinicaltrials.gov/show/NCT01162551

dbGaP phs001066 DNA and RNA Sequence of an Acute Lymphoblastic Leukemia - pht005280.v1.p1

- 23/06/2023 - 4 Formulaires, 1 Groupe Item, 3 Eléments de données, 1 Langue
Groupe Item: pht005280
Principal Investigator: Richard K. Wilson, PhD, McDonnell Genome Institute, Washington University School of Medicine, St. Louis, MO, USA MeSH: Neoplasms,Leukemia https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs001066 We used massively parallel sequencing technology to profile the genomic DNA and RNA of tumor cells (leukemic bone marrow) and normal cells (skin biopsy) obtained from a single patient with Acute Lymphoblastic Leukemia (ALL), referred to throughout this study as 'ALL1'. Included in this study are samples obtained from a primary tumor, first relapse, second relapse and several intermediate timepoints. We identified somatic mutations present in each tumor by analysis of whole genome (WGS) and exome sequence data. Single nucleotide variants (SNVs) and small insertions and deletions were identified in both the exome and WGS data. Large copy number variations (CNVs) and structural variants (SVs) were identified in the WGS data. A custom capture reagent was designed to target most variants and used to generate deep validation sequence data. The expression status of all somatic variants was assessed by RNA-seq. The RNA-seq data was also used for gene expression analysis and gene fusion detection.

pht005281.v1.p1

1 Groupe Item 3 Eléments de données

pht005282.v1.p1

1 Groupe Item 2 Eléments de données

pht005283.v1.p1

1 Groupe Item 5 Eléments de données

CALGB-10501 Concerns About Cancer Progression Form NCT00513747

- 18/06/2015 - 1 Formulaire, 4 Groupes Item, 18 Eléments de données, 1 Langue
Groupes Item: Header, Patient demographics, Concerns About Cancer Assessment, Footer Module
CALGB-10501 Concerns About Cancer Progression Form NCT00513747 Early or Delayed Fludarabine and Rituximab in Treating Patients With Previously Untreated Chronic Lymphocytic Leukemia Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=340EDF8E-59EA-1F88-E044-0003BA3F9857

Leukemia NCT00898079 Follow-Up - Off Protocol Therapy Follow-up (OPTF) Report [ABTR01B1] - 2172125v3.0 - Off Protocol Therapy Follow-up (OPTF) Report [ABTR01B1]

- 09/01/2015 - 1 Formulaire, 4 Groupes Item, 23 Eléments de données, 1 Langue
Groupes Item: Header, Patient Status Information, Events of Interest., CCRR MODULE
Off Protocol Therapy Follow-up (OPTF) Report [ABTR01B1] Collecting and Storing Malignant, Borderline Malignant Neoplasms, and Related Samples From Young Patients With Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=C0DB9E9B-20A9-68CC-E034-0003BA12F5E7

Brain and Central Nervous System Tumors NCT00053963 Treatment - ADVL0212: Reporting Period Worksheet (Leukemia) - 2172521v3.0 - Reporting Period Worksheet (Leukemia ADVL0212)

- 12/03/2015 - 1 Formulaire, 7 Groupes Item, 66 Eléments de données, 1 Langue
Groupes Item: Header, Patient characteristics, Treatment, Concomitant Medication, New Cancer, Follow-Up, Adverse event
ADVL0212: Reporting Period Worksheet (Leukemia) FR901228 in Treating Children With Refractory or Recurrent Solid Tumors or Leukemia NCT00053963 Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=C0F387DC-C9D3-5664-E034-0003BA12F5E7

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial